Jonathan Robert Hunt
CIK 1375410 · Chief Accounting Officer · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$176.4K
Companies
2
Total Filings
20
Lifetime Open-Market Net
$234.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CATX | Chief Accounting Officer | 59,800 | $2.95 | $176.4K | $156.3K | 9 | 2026-03-04 |
| Perspective Therapeutics, Inc. (ISR) Delisted | Chief Financial Officer | 159,510 | $0.38 | $61.3K | $78.7K | 10 | 2022-12-05 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-07-28 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-09 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +39,000 | $11.2K | EDGAR |
| 2021-07-06 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-28 | Perspective Therapeutics, Inc. (ISR) Delisted | Buy (P) | +67,306 | $35.0K | EDGAR |
| 2020-06-25 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-09-04 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-06-10 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-07-18 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-05 | Perspective Therapeutics, Inc. (ISR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-03-07 | — | Grant (A) | — | $0 |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.